BIOTON S.A. (WSE:BIO)
Poland · Delayed Price · Currency is PLN 4.240
-0.010 (-0.24%)
Mar 23, 2026, 5:00 PM CET
BIOTON Revenue
In the year 2025, BIOTON had annual revenue of 282.52M PLN with 35.98% growth. BIOTON had revenue of 64.40M in the quarter ending December 31, 2025, a decrease of -17.11%.
Revenue
282.52M
Revenue Growth
+35.98%
P/S Ratio
1.29
Revenue / Employee
778.29K
Employees
364
Market Cap
364.06M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 282.52M | 74.76M | 35.98% |
| Dec 31, 2024 | 207.76M | 26.13M | 14.38% |
| Dec 31, 2023 | 181.64M | -51.52M | -22.10% |
| Dec 31, 2022 | 233.16M | 70.13M | 43.01% |
| Dec 31, 2021 | 163.03M | -58.75M | -26.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ryvu Therapeutics | 87.70M |
| Synthaverse | 71.76M |
| Mabion | 14.81M |
| Captor Therapeutics Spolka Akcyjna | 7.57M |
| Molecure | 5.86M |
| Urteste | 1.80M |
| Pharmena | 1.58M |
| Poltreg | 250.00K |